Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice (Q39502171)

12 September 2017

title

Synergistic activity of baicalein with ribavirin against influenza A (H1N1) virus infections in cell culture and in mice (English)

1 reference

12 September 2017

1 reference

Lili Chen

1 reference

12 September 2017

Jie Dou

1 reference

12 September 2017

Zhenzhen Su

1 reference

12 September 2017

Huimin Zhou

1 reference

12 September 2017

Hui Wang

1 reference

12 September 2017

Weidong Zhou

1 reference

12 September 2017

Qinglong Guo

1 reference

12 September 2017

Changlin Zhou

1 reference

12 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21782851

7 December 2024

publication date

18 July 2011

1 reference

full work available at URL

12 September 2017

https://api.elsevier.com/content/article/PII:S0166354211003792?httpAccept=text/xml

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

https://api.elsevier.com/content/article/PII:S0166354211003792?httpAccept=text/plain

7 December 2024

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

7 December 2024

1 reference

12 September 2017

1 reference

12 September 2017

1 reference

12 September 2017

page(s)

314-320

1 reference

Amantadine- and oseltamivir-resistant variants of influenza A viruses in Thailand.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Mechanism and Specificity of Action of Ribavirin

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

The broad-spectrum antiviral ribonucleoside ribavirin is an RNA virus mutagen

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Ribavirin's antiviral mechanism of action: lethal mutagenesis?

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Effects of baicalein on Sendai virus in vivo are linked to serum baicalin and its inhibition of hemagglutinin-neuraminidase.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Clinical review of ribavirin.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Influenza, an existing public health problem

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Differential patterns of amantadine-resistance in influenza A (H3N2) and (H1N1) isolates in Toronto, Canada

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Aurintricarboxylic acid inhibits influenza virus neuraminidase

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Inhibition of influenza virus replication by plant-derived isoquercetin

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Baicalin, an inhibitor of HIV-1 production in vitro

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Subunit interactions of vesicular stomatitis virus envelope glycoprotein stabilized by binding to viral matrix protein

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Triple combination of oseltamivir, amantadine, and ribavirin displays synergistic activity against multiple influenza virus strains in vitro.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in vitro

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Inhibition of reverse transcriptase activity by a flavonoid compound, 5,6,7-trihydroxyflavone

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Metabolism and antiviral activity of ribavirin

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

A three-dimensional model to analyze drug-drug interactions

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Neuraminidase inhibitor resistance in influenza viruses.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Effects of double combinations of amantadine, oseltamivir, and ribavirin on influenza A (H5N1) virus infections in cell culture and in mice

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Effects of the combination of favipiravir (T-705) and oseltamivir on influenza A virus infections in mice

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviral effects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Ribavirin and lethal mutagenesis of poliovirus: molecular mechanisms, resistance and biological implications

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Flavonoid baicalein suppresses adhesion, migration and invasion of MDA-MB-231 human breast cancer cells

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

Inhibitory effects of baicalein on the influenza virus in vivo is determined by baicalin in the serum

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

The effects of ketorolac tromethamine and baicalein on the levels of inflammatory factors in human synoviocytes

7 December 2024

1 reference

https://api.crossref.org/works/10.1016/J.ANTIVIRAL.2011.07.008

7 December 2024

Identifiers

DOI

1 reference

12 September 2017

1 reference